All pages
Jump to navigation
Jump to search
- "Parkinson's-plus"
- "clipping"
- (18F)-ML-10
- (18F)-labeled substance P antagonist receptor quantifier
- (18F)-లేబుల్ చేయబడ్డ పదార్థం P ప్రతినాయక గ్రాహక పరిమాఫైర్
- (18F)L-FAC
- (18F)L-FMAC
- (18F) L-FMAC
- (18F) L-ఎఫ్ ఎసి
- (61)Cu-ATSM
- (ADCC)
- (Articulationes Sternocotales; Costosternal Articulations) (Fig. 315)
- (CDC)
- (Central) Auditory Processing Disorder
- (E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate
- (EPSP)
- (F-18)HX4
- (F-18) HX4
- (F18)VM4-037
- (F18) VM4-037
- (GnRH)
- (HDN)
- (MDR-TB)
- (MRSA)
- (NADP
- (National) Food Safety Initiative
- (R)-3-Nitrobiphenyline
- (RFLP)
- (Rock) Cornish Fryer, Roaster, or Hen
- (Rock) Cornish Game Hen
- (SCID)
- (VISA)
- (VRSA)
- (b-HCG)
- )
- -paresis or -plegia
- 0201-restricted cytomegaloviral epitope CMVpp65(495-503) with potential immunostimulatory and antitumor activities. Upon subcutaneous administration, CMVpp65-A
- 0201 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A
- 0201 peptide vaccine
- 0201 peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against CMV-positive cells, resulting in cell lysis. HLA-A
- 1,3-Benzodioxolyl-N-ethylpentanamine
- 1,3-Benzodioxolyl-N-methylpentanamine
- 1,4-Butanediol
- 1-(2’-deoxy-2’-fluoro-β-D-arabinofuranosyl) uracil
- 1-(4-(Trifluoromethyl)phenyl)piperazine
- 1-methyl-d-tryptophan
- 10-Deacetylbaccatin
- 10-propargyl-10-deazaaminopterin
- 10 Essential Public Health Services
- 10p13-p14 Deletion Syndrome
- 10p13-p14 deletion syndrome
- 11-Beta-Hydroxylase Deficiency
- 11-beta-hydroxylase deficiency
- 11-beta-hydroxysteroid dehydrogenase type 1 deficiency
- 111In-Zevalin
- 111In-ibritumomab tiuxetan
- 11C-acetate
- 11C-choline
- 11C-choline PET-CT scan
- 11C topotecan
- 11C టొపొనేక్టన్
- 11 Beta-Hydroxysteroid Dehydrogenase Type 2 Deficiency
- 11 beta-hydroxysteroid dehydrogenase type 2 deficiency
- 11beta-hydroxysteroid dehydrogenase type 1 inhibitor AZD4017
- 11beta-హైడ్రాక్సిస్టెరాయిడ్ డీహైడ్రోజెనేజ్ టైప్ 1 ఇన్హిబిటర్ AZD4017
- 12-O-tetradecanoylphorbol-13-acetate
- 123-I-MIP-1095
- 123I-MIBG
- 126–F
- 13-cis retinoic acid
- 131I-MIBG
- 140-01-21-020
- 14C BMS-275183
- 14C బిఎమ్ ఎస్-275183
- 1572 form
- 16, 16-dimethyl prostaglandin E2
- 16, 16-డైమిథైల్ ప్రోస్టాగ్లాండిన్ E2
- 17-AAG
- 17-N-allylamino-17-demethoxygeldanamycin
- 17-Phenylandrostenol
- 17-alpha-hydroxylase/17,20 lyase deficiency
- 17-beta-hydroxysteroid dehydrogenase 3 deficiency
- 17-dimethylaminoethylamino-17-demethoxygeldanamycin
- 18-F-fluoroacetate
- 18F-16 alpha-fluoroestradiol
- 18F-EF5
- 18F-FES
- 18F-FHBG
- 18F-FLT
- 18F-FMCH
- 18F-MISO
- 18F-NaF PET
- 18F-choline
- 18F-fludeoxyglucose
- 18F-fluoromethylcholine
- 18F-fluoromisonidazole
- 18F-fluorothymidine
- 18F-labeled mini-PEG spacered RGD dimer
- 18F-sodium fluoride positron emission tomography
- 19-Iodocholesterol
- 1H-nuclear magnetic resonance spectroscopic imaging
- 2'-F-ara-deoxyuridine
- 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a
- 2-(2,5-Dimethoxy-4-bromobenzyl)-6-(2-methoxyphenyl)piperidine
- 2-0, 3-0 desulfated heparin
- 2-0, 3-0 డీసులేఫేటెడ్ హెపారిన్
- 2-D mammography
- 2-dimensional mammography
- 2-fluorofucose-containing SGN-2FF
- 2-fluoropropionyl-labeled pegylated dimeric RGD peptide
- 2-hydroxyflutamide depot
- 2-hydroxyoleic acid
- 2-methoxyestradiol
- 2-ఫ్లోరోక్లోస్-కలిగి ఉన్న ఎస్ గ్దాదీ-2FF
- 2-ఫ్లోరోప్రోపినేల్-లేబుల్ పెగ్యలేటెడ్ డిమెరిక్ ఆర్ జిడి పెప్టైడ్
- 2-మెథక్స్యేస్ట్రాడియోల్
- 2-హైడ్రాక్సిఫ్లుటామైడ్ డిపో
- 2-హైడ్రాక్సియోలిక్ ఆమ్లం
- 20/20 vision
- 2012 Pakistan fake medicine crisis
- 2013 Huang Case in Qatar
- 20 meter pacer test
- 21-Hydroxylase
- 21-gene signature
- 21-hydroxylase deficiency
- 22-Dihydroergocalciferol
- 22q13 deletion syndrome
- 22q deletion syndrome(s)
- 24-hour urine protein
- 24/7
- 25CN-NBOH
- 26-deoxyactein
- 2G-1 TCR retroviral vector-transduced lymphocytes
- 2G-1 TCR రెట్రోవైరల్ వెహికల్-ట్రాన్సఫర్ లింఫో సైట్లు
- 2IT-BAD monoclonal antibody 170
- 2 '-ఊ-ర-డీఆక్సీరైడిన్
- 2q37 deletion syndrome
- 2q37 monosomy
- 3'-C-ethynylcytidine
- 3'-aminomethyl nicotine-P. aeruginosa r-exoprotein A conjugate vaccine
- 3' end
- 3,3'-Diindolylmethane
- 3,4-benzpyrene
- 3,4-methylenedioxymethamphetamine
- 3, 4-మిథైలెనెడిక్సియాంపీటాంహీట్
- 3-AP
- 3-D
- 3-D mammography
- 3-Iodotyrosine
- 3-Monoacetylmorphine
- 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
- 3-beta-hydroxysteroid dehydrogenase deficiency
- 3-deazauridine
- 3-dimensional
- 3-dimensional conformal radiation therapy
- 3-dimensional mammography
- 3-dimensional radiation therapy
- 3-methylglutaconic aciduria type 1
- 3-డీఅజౌరిడిన్
- 3. The Arteries of the Head and Neck. a. The Common Carotid Artery
- 3D-CRT
- 3D-expanded placenta-derived cells PLX-R18
- 3D-విస్తరించిన ప్లాసెంటా-డిరైవ్డ్ సెల్స్ PLX-R18
- 3F8
- 3T MRI
- 3 '-C-ఎథినిక్ సైటిడిన్
- 3 '-అమినోమెథైల్ నికోటిన్-P. ఎరుగినోస ఆర్-ఎక్సాప్రోటీన్ ఎ కాంజుగేట్ వ్యాక్సిన్
- 3 Tesla MRI
- 3 Tesla magnetic resonance imaging
- 3’-deoxy-3’-(18F) fluorothymidine
- 4'-iodo-4'-deoxydoxorubicin
- 4-18F fluoroglutamic acid
- 4-18F ఫ్లోరోగ్లోటామిక్ ఆమ్లం
- 4-AcO-DALT
- 4-Fluoroethcathinone
- 4-HO-DSBT
- 4-NQO
- 4-Nitroquinoline 1-oxide
- 4-demethoxydaunorubicin
- 4-hydroxytamoxifen
- 4-nitroestrone 3-methyl ether
- 4-nitroquinoline 1-oxide
- 4-peptide melanoma vaccine
- 4-thio-2-deoxycytidine
- 4-థియో-2-డీఆక్సీసైటిడిన్
- 4-నైట్రోస్ట్రిన్ 3-మిథైల్ ఈథర్
- 4-పెప్టైడ్ మెలనోమా వ్యాక్సిన్
- 4. The Arteries of the Upper Extremity. a. The Subclavian Artery
- 4. The Thoracic Cavity
- 41 csa cases
- 45,x/46,xy gonadal dysgenesis
- 454 sequencing (pyrosequencing)
- 45 CFR 46
- 45 Code of Federal Regulations Part 46
- 46,xx/46,xy ovotesticular differences of sex development
- 46,xx differences of sex development
- 46,xx gonadal dysgenesis
- 46,xx ovotesticular difference of sex development
- 46,xx testicular differences of sex development
- 46,xy differences of sex development
- 46,xy disorder of androgen action
- 46,xy gonadal dysgenesis
- 46,xy ovotesticular differences of sex development
- 460 BC
- 47,XXX Syndrome
- 47,XYY Syndrome
- 47,xxx syndrome
- 47,xyy syndrome
- 4H11-28z/fIL-12/EGFRt-expressing autologous T lymphocytes
- 4H11-28z/fIL-12/EGFRt-వ్యక్తీకరించే ఆటోలాఘస్ T లింఫోసైట్లు
- 4SCAR-GD2-modified T lymphocytes
- 4SCAR-GD2-సవరించిన T లింఫోసైట్లు
- 4 '-ఐయోడో-4'-డీఆక్సీడోక్సోరూబిని
- 4th Street Food Co-op
- 5' end
- 5,10-methylenetetrahydrofolate reductase deficiency
- 5-18F fluorouracil
- 5-18F ఫ్లోరోసికిల్
- 5-Ethoxy-DMT
- 5-FITC-labeled GI-heptapeptide
- 5-FITC-labeled colon-heptapeptide
- 5-FITC-లేబుల్ జిఐ-హెప్టాప్టైడ్
- 5-FITC-లేబుల్ వేయబడ్డ పెద్దపేగు-హెప్టాఎపిటైడ్
- 5-FU
- 5-FU/LV
- 5-HO-DiPT
- 5-HT3 receptor antagonist
- 5-HTTLPR
- 5-HT antagonist
- 5-Hydroxytryptophan
- 5-alpha-reductase deficiency
- 5-alpha reductase inhibitor
- 5-alpha reductase inhibitors
- 5-aza-4’-thio-2’-deoxycytidine
- 5-fluoro-2-deoxycytidine
- 5-fluorouracil
- 5-fluorouracil/salicylic acid topical solution
- 5-hydroxyindoleacetic acid
- 5-hydroxytryptamine
- 5-hydroxytryptamine 3 receptor antagonist
- 5-అజా-4'-థియో-2'-డీఆక్సీసైటిడిన్
- 5-ఫ్లోరో-2-డీఆక్సీసైటిడిన్
- 5-ఫ్లోరౌజిల్/సాలిసిలిక్ యాసిడ్ సమయోచిత ద్రావణం
- 50% oxygen/50% nitrous oxide premix
- 50% ఆక్సిజన్/50% నైక్రోనస్ ఆక్సైడ్ ప్రీమిక్స్
- 504 plan
- 504 plans
- 506U78
- 55 csa cases
- 5:2 diet
- 5BX
- 5 A Day
- 5 A Day Adventures
- 5 alpha steroid reductase 2 deficiency
- 5e. Costovertebral Articulations
- 5q- syndrome
- 5q minus syndrome
- 5’ cap
- 6,8-bis(benzylthio)octanoic acid
- 6, 8-బిస్ (బెంజీలేథియో) ఆక్టానోయిక్ ఆమ్లం
- 6-Fluoro-AMT
- 6-Monoacetylmorphine
- 6-azauridine
- 6-hydroxymethylacylfulvene
- 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatases isoform 3 inhibitor ACT-PFK-158
- 6-thioguanine
- 6-అజౌరిడిన్
- 6-ఫాస్ఫేట్-2-కిన్సే/ఫ్రక్టోజ్-2, 6-బయోఫాస్ఫోడీలు ఐసోఫారం 3 ఇన్హిబిటర్ యాక్ట్-PFK-158
- 61 Cu-ATSM
- 6 melanoma helper peptide vaccine
- 6 మెలనోమా హెల్పర్ పెప్టైడ్ వ్యాక్సిన్
- 7-Dehydrocholesterol
- 7-cyanoquinocarcinol
- 7-hydroxystaurosporine
- 7-హైడ్రాక్సిస్టౌరోస్పోరిన్
- 70-gene signature
- 70S ribosome
- 7beta-hydroxysteroid dehydrogenase type 5 inhibitor ASP9521
- 7beta-హైడ్రాక్సిస్టెరాయిడ్ డీహైడ్రోజెనేజ్ టైప్ 5 ఇన్హిబిటర్ ASP9521
- 8-hydroxyquinoline sulfate ointment
- 8-హైడ్రాక్సిక్వినైన్ సల్ఫేట్ ఆయింట్ మెంట్
- 8-హైడ్రాక్సిక్వినైన్ సల్ఫేట్ ఆయింట్ మెంట్/en
- 80S ribosome
- 851B gel
- 852A
- 9-Carboxymethoxymethylguanine
- 9-cis retinoic acid
- 90Y-DOTA-biotin
- 90Y-Zevalin
- 90Y-ibritumomab tiuxetan
- 99m-Tc-Dx
- 9brinogen
- 9broelastic membrane
- 9cUAB30
- 9p21
- ? stereoisomers
- A
- A-101 topical solution
- A-349,821
- A-B exotoxin
- A-Hydrocort
- A-fib
- A1C
- A1 hydronephrosis
- A2/3 hydronephrosis
- A33
- A6
- A8erent arteriole
- AAA
- AAA)
- AAA screening
- AAP
- ABBV-221
- ABCA1 pathway
- ABCDE rule
- ABCD rating
- ABG
- ABI-007
- ABO Blood Groups
- ABO blood group
- ABO blood group system
- ABO blood groups
- ABR test
- ABT-263
- ABT-510
- ABT-751
- ABT-869
- ABT-888
- ABVD
- ABVD regimen
- ABVE
- ABVE-PC
- ABVE-PC regimen
- ABVE regimen
- ABX-EGF
- AC
- AC-T
- AC-T-T
- AC-T-T regimen
- AC-TH regimen
- AC-T regimen
- AC-Taxol regimen
- ACAPHA
- ACE
- ACES (nutritional supplement)
